SIO GENE THERAPIES INC (SIOX) Forecast, Price Target & Analyst Ratings

NASDAQ:SIOX • US8293991043

Current stock price

0.415 USD
+0.01 (+2.09%)
At close:
0.4151 USD
+0 (+0.02%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SIO GENE THERAPIES INC (SIOX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.10
+ 1,128.92% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Jun 12, 2023
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
85.71%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.10
Upside
+ 1,128.92%
From current price of $0.42 to mean target of $5.10, Based on 7 analyst forecasts
Low
$5.05
Median
$5.10
High
$5.25

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

7 Wall Street analysts provided a forecast for the next 12 months for SIOX. The average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SIOX Current Analyst RatingSIOX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0.5 1 1.5 2 2.5

Analyst Ratings History

SIOX Historical Analyst RatingsSIOX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
85.71%
SIOX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about SIOX.
In the previous month the buy percentage consensus was at a similar level.
SIOX was analyzed by 7 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2022-04-28Cantor FitzgeraldDowngrade Overweight -> Neutral
2022-04-28HC Wainwright & Co.Downgrade Buy -> Sell
2022-02-01SVB LeerinkDowngrade Outperform -> Market Perform
2022-02-01HC Wainwright & Co.Maintains Buy
2021-10-21HC Wainwright & Co.Maintains Buy
2021-08-12SVB LeerinkMaintains Outperform
2021-06-15BTIGInitiate Buy
2021-04-30HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Jun 12, 2023

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A

Next Earnings Summary

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2015 2016 2017 2018 2019 2020 2021 2022
Revenue
YoY % growth
SIOX revenue by date.SIOX revenue by date.
EBITDA
YoY % growth
SIOX ebitda by date.SIOX ebitda by date.
N/A-133.15M-180.25M
-35.37%		-210.24M
-16.64%		-124.57M
40.75%		-67.69M
45.66%		-41.252M
39.06%		-71.294M
-72.83%
EBIT
YoY % growth
SIOX ebit by date.SIOX ebit by date.
-21.05M-133.16M
-532.59%		-180.5M
-35.55%		-213.32M
-18.18%		-127.02M
40.46%		-69.17M
45.54%		-42.197M
39.00%		-71.562M
-69.59%
Operating Margin
SIOX operating margin by date.SIOX operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
SIOX eps by date.SIOX eps by date.
N/A-9.04-14.56
-61.06%		-16.48
-13.19%		-8.69
47.27%		-3.00
65.48%		-0.66
78.00%		-0.98
-48.48%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

EPS
Q2Q % growth
Revenue
Q2Q % growth
EBITDA
Q2Q % growth
EBIT
Q2Q % growth

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SIOX Yearly EPS VS EstimatesSIOX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 -5 -10 -15

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
N/A
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SIO GENE THERAPIES INC / SIOX Forecast FAQ

What is the average price target for SIO GENE THERAPIES INC (SIOX) stock?

7 analysts have analysed SIOX and the average price target is 5.1 USD. This implies a price increase of 1128.92% is expected in the next year compared to the current price of 0.415.

What is the next earnings date for SIOX stock?

SIO GENE THERAPIES INC (SIOX) will report earnings on 2023-06-12, before the market open.

How many analysts cover SIO GENE THERAPIES INC (SIOX) stock?

The number of analysts covering SIO GENE THERAPIES INC (SIOX) is 7.